Molecular Partners AG
MOLN
$4.45
$0.133.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -19.79% | -2.13% | |||
| Gross Profit | 19.79% | 2.13% | |||
| SG&A Expenses | -7.00% | 3.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.31% | -0.75% | |||
| Operating Income | 16.31% | 0.75% | |||
| Income Before Tax | 40.16% | -32.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.16% | -32.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.16% | -32.55% | |||
| EBIT | 16.31% | 0.75% | |||
| EBITDA | 16.88% | 1.11% | |||
| EPS Basic | 40.18% | -30.72% | |||
| Normalized Basic EPS | 32.06% | -13.95% | |||
| EPS Diluted | 40.18% | -30.72% | |||
| Normalized Diluted EPS | 32.06% | -13.95% | |||
| Average Basic Shares Outstanding | 0.02% | 1.40% | |||
| Average Diluted Shares Outstanding | 0.02% | 1.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||